Full View

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Z Eroglu, A Ribas - Therapeutic advances in medical …, 2016 - journals.sagepub.com
Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …
被引用次数：339 相关文章

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy.

Z Eroglu, A Ribas - Therapeutic Advances in Medical …, 2016 - search.ebscohost.com
Abstract Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Z Eroglu, A Ribas - Therapeutic Advances in Medical Oncology, 2016 - escholarship.org
Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy.

Z Eroglu, A Ribas - Therapeutic Advances in Medical Oncology, 2016 - europepmc.org
Abstract Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Z Eroglu, A Ribas - Therapeutic Advances in Medical Oncology, 2015 - cir.nii.ac.jp
抄録< jats: p> Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients
with advanced BRAFV600 mutated melanoma has shown objective tumor responses in …

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Z Eroglu, A Ribas - Therapeutic advances in medical …, 2016 - pubmed.ncbi.nlm.nih.gov
Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …
[HTML] nih.gov

[HTML][HTML] Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Z Eroglu, A Ribas - Therapeutic Advances in Medical Oncology, 2016 - ncbi.nlm.nih.gov
Abstract Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy.

Z Eroglu, A Ribas - Therapeutic Advances in Medical Oncology, 2016 - europepmc.org
Abstract Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with
advanced BRAFV600 mutated melanoma has shown objective tumor responses in …